My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 561

    1.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

    Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH.

    Diabetes Care. 1999 Mar;22(3):491-4.PMID: 10097934 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1997 Jul;46(7):1182-8.PMID: 9200654 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.

    Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J.

    Clin Sci (Lond). 1998 Dec;95(6):709-17.PMID: 9831696 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.

    Rossing K, Christensen PK, Jensen BR, Parving HH.

    Diabetes Care. 2002 Jan;25(1):95-100.PMID: 11772908 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al.

    Cooper ME.

    Diabetes Care. 2000 Dec;23(12):1723-4. No abstract available. PMID: 11128340 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

    Rossing K, Jacobsen P, Pietraszek L, Parving HH.

    Diabetes Care. 2003 Aug;26(8):2268-74.PMID: 12882847 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1994 Sep;43(9):1108-13.PMID: 8070610 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).

    [No authors listed]

    Diabetes. 2001 Apr;50(4):843-50.PMID: 11289051 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.

    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.

    J Hum Hypertens. 1993 Aug;7(4):333-9.PMID: 8410924 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

    Diabet Med. 2004 Nov;21(11):1192-9.PMID: 15498085 [PubMed - indexed for MEDLINE]Related articles

    15.

    Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

    Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

    Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.

    Poulsen PL, Ebbehøj E, Mogensen CE.

    J Intern Med. 2001 May;249(5):433-40.PMID: 11350567 [PubMed - indexed for MEDLINE]Related articles

    17.

    Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Kidney Int. 2002 Jul;62(1):192-8.PMID: 12081578 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

    Parving HH, Hommel E, Jensen BR, Hansen HP.

    Kidney Int. 2001 Jul;60(1):228-34.PMID: 11422755 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH.

    Scand J Clin Lab Invest. 1997 Aug;57(5):427-34.PMID: 9279969 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.

    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.

    BMJ. 1996 Sep 7;313(7057):591-4.PMID: 8806248 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity